BMRN
Biomarin Pharmaceutical Inc.
$63.45
Earnings Summary
Revenue | $733.87Mn |
Net Profits | $106.08Mn |
Net Profit Margins | 14.45% |
Highlights
Biomarin Pharmaceutical Inc.’s revenue jumped 25.24% since last year same period to $733.87Mn in the Q3 2024. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated 3.56% jump in its revenue since last 3-months.
Biomarin Pharmaceutical Inc.’s net profit jumped 162.72% since last year same period to $106.08Mn in the Q3 2024. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated -1.02% fall in its net profits since last 3-months.
Biomarin Pharmaceutical Inc.’s net profit margin jumped 109.77% since last year same period to 14.45% in the Q3 2024. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated -4.42% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Biomarin Pharmaceutical Inc. post its latest quarter earnings
EPS Estimate Current Quarter | 0.52 |
EPS Estimate Current Year | 0.52 |
Highlights
Biomarin Pharmaceutical Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.52 - a 48.57% jump from last quarter’s estimates.
Biomarin Pharmaceutical Inc.’s earning per share (EPS) estimates for the current year stand at 0.52.
Key Ratios
Key ratios of the Biomarin Pharmaceutical Inc. post its Q3 2024 earnings
Earning Per Share (EPS) | 0.55 |
Highlights
Biomarin Pharmaceutical Inc.’s earning per share (EPS) jumped 161.9% since last year same period to 0.55 in the Q3 2024. This indicates that the Biomarin Pharmaceutical Inc. has generated 161.9% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-05 | 0.35 | 0.56 | 60% |
2024-10-31 | 0.52 | 0.55 | 5.77% |
2024-04-26 | 0.35 | 0.46 | 31.43% |
₹0 US Stocks a/c Opening Fee